CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- 4 Grant or award Director acquired 6,157 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 2,407 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 873 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 5,132 shares (to pay taxes)
- 4 Grant or award Director acquired 5,628 shares (grant or award)
- 4 Grant or award Director acquired 7,842 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,339 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 836 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & General Counsel gave up 2,833 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 12,820 shares (to pay taxes)
Page 2 of 10 · 193 filings